Belviq and Percocet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Belviq (lorcaserin hydrochloride) and Percocet (acetaminophen; oxycodone hydrochloride). Common drug interactions include weight increased among females and change of bowel habit among males.

The phase IV clinical study analyzes what interactions people have when they take Belviq and Percocet. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Belviq?

Belviq has active ingredients of lorcaserin hydrochloride. It is often used in weight loss. eHealthMe is studying from 3,179 Belviq users. Check the latest studies of Belviq.

What is Percocet?

Percocet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 119,838 Percocet users. Check the latest studies of Percocet.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

31 people who take Belviq and Percocet together, and have interactions are studied.

Belviq and Percocet drug interactions.

What are the common drug interactions of Belviq and Percocet, by gender? *:

female:

  1. Weight increased
  2. Drug ineffective
  3. Nausea (feeling of having an urge to vomit)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Cerebrospinal fluid leakage
  6. Chronic kidney disease
  7. Death
  8. Fall
  9. Implant site pain
  10. Renal failure (kidney dysfunction)

male:

  1. Change of bowel habit
  2. Energy increased
  3. Nausea (feeling of having an urge to vomit)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Type 2 diabetes mellitus
  6. Erection increased
  7. Fatigue (feeling of tiredness)
  8. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  9. Weight increased
  10. Haematoma (collection of blood outside the blood vessels)

What are the common drug interactions of Belviq and Percocet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

  1. Cerebrospinal fluid leakage
  2. Chronic kidney disease
  3. Death
  4. Fall
  5. Implant site pain
  6. Renal failure (kidney dysfunction)
  7. Abdominal pain
  8. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

40-49:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Dizziness
  3. Hysterectomy
  4. Nausea (feeling of having an urge to vomit)
  5. Pancreatitis (inflammation of pancreas)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Type 2 diabetes mellitus

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Weight increased

60+:

  1. Weight increased
  2. Fatigue (feeling of tiredness)
  3. Constipation
  4. Fungal infection
  5. Bladder pain
  6. Headache (pain in head)
  7. Urethral pain
  8. Urinary tract infection
  9. Drug ineffective
  10. Change of bowel habit

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 35.48%
  2. Stress And Anxiety: 10 people, 32.26%
  3. Depression: 9 people, 29.03%
  4. Diabetes: 8 people, 25.81%
  5. High Blood Cholesterol: 8 people, 25.81%
  6. Weight Increased: 8 people, 25.81%
  7. Osteoporosis (bones weak and more likely to break): 6 people, 19.35%
  8. Muscle Disorder (muscle disease): 6 people, 19.35%
  9. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 19.35%
  10. Oral Herpes (viral infection of mouth): 6 people, 19.35%

* Approximation only. Some reports may have incomplete information.

Do you take Belviq and Percocet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Belviq and Percocet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Belviq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Percocet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Belviq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Percocet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorcaserin hydrochloride and acetaminophen; oxycodone hydrochloride (the active ingredients of Belviq and Percocet, respectively), and Belviq and Percocet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: